Back

CSF2-driven myeloid reprogramming onnects metabolic stress to pulmonary vascular remodeling in HFpEF

18 April 2026 (14:45 - 15:00)
Organised by: Logo
Congress Presentation Part of: Young Investigators Award Hypertension, Pulmonary Hypertension Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Ms Valeria Masciovecchio

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
Atrial tissue engineering using conditionally immortalized human myocytes: establishing matured and geometrically defined 3D models of atrial arrhythmias
Mr A. Nobacht (Leiden, NL)
Abstract Slides
Presentation thumbnail
The novel ErbB4 agonist JK07 modulates gene expression in key cardiac cells. insights from single-nuclei transcriptomics in a murine heart failure model
Miss C. Civati (Antwerp, BE)
Abstract Slides
Presentation thumbnail
Inhibition of dysregulated il-8-cxcr1 paracrine cellular crosstalk reverses cardiac hypertrophy and fibrosis in noonan syndrome
Mr F. Koitka (Goettingen, DE)
Abstract Slides
Presentation thumbnail
Exploring cardiomyocytes-endothelial cell communication to promote cardiac revascularization and regeneration
Mrs F. Longo (Trieste, IT)
Abstract Slides
Presentation thumbnail
BUD13 as a novel mediator of vascular endothelial dysfunction associated with type 2 diabetes
Doctor A. Santana Garrido (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Young Investigators Award

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

18 April 2026 14:45 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources